Neoadjuvant Hormonal Treatment and Radiotherapy for Prostate Cancer
| Autor: | Richard Pötter, Stefan Wachter, Natascha Wachter-Gerstner |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Male
Subset Analysis Oncology Cancer Research medicine.medical_specialty Antineoplastic Agents Hormonal medicine.medical_treatment Prostate cancer Prostate Internal medicine Biopsy Humans Medicine Randomized Controlled Trials as Topic Retrospective Studies Chemotherapy medicine.diagnostic_test business.industry Prostatic Neoplasms Androgen Antagonists Hormone replacement therapy (menopause) General Medicine medicine.disease Radiation therapy Treatment Outcome medicine.anatomical_structure Chemotherapy Adjuvant Goserelin Hormonal therapy Radiotherapy Adjuvant Leuprolide business |
| Zdroj: | Oncology. 65:29-33 |
| ISSN: | 1423-0232 0030-2414 |
| DOI: | 10.1159/000072489 |
| Popis: | Adjuvant hormone treatment with radiotherapy has been demonstrated in two studies (Bolla and RTOG 8531) to be beneficial in patients with locally advanced prostate cancer. However, the vast majority of patients with early prostate cancer can be cured with radiotherapy alone. Subset analysis combining RTOG 8610 and RTOG 8531 has demonstrated a survival benefit only for patients with a biopsy Gleason score ≤6 after short-term neoadjuvant hormonal therapy. The results of ongoing research will further clarify the use of hormone treatment with radiotherapy in patients with low and intermediate risk. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|